I AM Healthy Money

From a $7 million raise in Dubai to talk of AI "digital twins," this episode cuts through the noise around longevity: what’s real, what’s hype, and how to build a sane, evidence-based approach to living longer. It highlights Longevium’s plan for an AI-powered research lab, the promise and limits of new tech, and the danger of marketing-driven snake oil.

More importantly, it returns to practical fundamentals—move (especially strength + cardio), eat a Mediterranean-style, protect sleep, nurture social ties, reduce toxins, and be skeptical of miracle claims—while advocating for joy, minimal effective doses, and technology as decision support, not a replacement for basics.

Inside Vladimir Putin’s reported $26 billion pursuit of longevity lies a mix of science, ambition, and national strategy — from genetically engineered mini-pigs and organ printing to cryotherapy and advanced genetic research. This episode links that cultural fascination with a practical, operational view of longevity: using prescriptive analytics and real-time guidance to extend the life of both machines and people.

Through a grocery-freezer-before-Thanksgiving anecdote, we show how detecting weak signals and routing technicians smartly saves inventory, reputation, and labor, while applying the same philosophy to the workforce reduces burnout, errors, and turnover. The takeaway: invest in preventive care for assets and employees to build resilience, reduce emergency costs, and preserve institutional knowledge.

In a single episode we trace how housing shortfalls, soaring insurance and retirement costs, and breakthroughs in weight-loss and longevity medicine connect into one big affordability problem.

We explore why home construction lags, why premiums are exploding, why retirees tap home equity, how new multi-hormone drugs promise dramatic weight loss, and why Silicon Valley is treating aging like an engineering challenge—then ask whether ordinary people can afford a longer life.

On an ordinary day life can pivot—this episode urges you to stop postponing the important: ten specific, heartfelt lines to say to your mom while you still can, and how those small truths bring real closure.

It also connects sleeping better, using empathy to end arguments, and a surprising study showing the brain’s hidden language processing under anesthesia—all pointing to one theme: time matters. Say the thing, sleep well, and be kinder to one another now.

Longevity travel is booming and splits into two clear paths: Blue Zone immersion—experiential trips that teach healthier rhythms through place, movement, food, and social connection—and clinical longevity retreats—medical, diagnostics-driven programs that measure biomarkers and deliver targeted interventions.

Choose the lane that matches your goals, budget, and tolerance for intervention: adopt lifestyle cues at Blue Zone destinations for lasting habit change, or opt for clinical clinics for measurable resets; always check test transparency, data privacy, evidence for claims, and meaningful aftercare.

Kimberly breaks down modern reverse mortgages—what’s changed, who they help, and why "paying cash" isn’t always the safest choice in retirement.

Through stories, data, and clear guidance, learn when a HECM for Purchase or a reverse mortgage line of credit can preserve liquidity, reduce risk, and support smarter retirement moves.

This episode explores how rising life expectancy is forcing a rethink of money, health and everyday services. From UK life-table projections that make 100 a realistic outcome for many born in 2049, to touring artists managing post-show crashes, to hotels and clinics redesigning menus and services for recovery and longevity, the show connects big-picture policy challenges with practical, human strategies. It examines retirement planning, housing wealth, wellness businesses, and the growing market for longevity interventions—arguing that longer lives require deeper planning and new systems to support them.

Subscribe to i am healthy money for more research-driven episodes and stick around for a preview of the next project at the end.

Late-week geopolitics derail a calm market: Iran’s rejected counterproposal lifts oil prices, reigniting inflation fears and pushing bond yields and mortgage rates higher after a five-day rally.

Amid the market noise, Longbridge Financial posts a staggering Q1 profit that reshapes investor expectations, while investors also pour money into longevity plays—from inflammation research and regenerative medicine to cheaper genome sequencing and firm buy ratings.

Researchers offer a human angle: long-lived caregiving—especially mothers—may have shaped our lifespan, and social connection remains a key piece of staying healthy. Practical takeaway: watch oil for mortgage-rate risk, and watch evidence for longevity claims.

This episode ties together one week where AI, housing and longevity collided: a headline-grabbing claim that Trump could be remembered as the "AI President," OpenAI employees suddenly able to cash out life-changing sums, and a housing market wobbling around 6.4% mortgages with refis and applications falling.

We unpack the small-but-significant moves in rates, steady unemployment, tight inventory and record average loan sizes that are squeezing entry-level buyers, alongside the wellness trend chasing longevity metrics like HRV, simple practices dubbed "Vitamin W," and biotech buzz from NMN to GLP-1 drugs.

Ultimately the episode asks how we buy the future—through tech, real estate or health—and offers a practical takeaway: focus on what you can do today—build, run the numbers, and keep moving—because headlines won’t decide your future.

Walk through a night in New York where a glittering skincare launch sits beside deeper questions: is longevity the new luxury? This episode takes a wide-angle view — from glamorous beauty campaigns and thymus research to coffee science, mortgage strain on older homeowners, and Microsoft’s push to revive a nuclear site to power AI. We explore how lifespan trends touch culture, finance, healthcare, and energy, and ask who really gets to afford a longer life.

Along the way we unpack simple, science-backed actions that can lower biological age, the financial pressures facing aging homeowners, and the surprising ways technology and human biases are shaping the future. It’s a conversation about time, investment, and the systems we need to live better, longer.